Hints and tips:
Related Special Reports
...In a speech at Monday’s gathering, Gates is expected to underscore the case for making nutrition and gut microbes — known as the microbiome — a leading area of international research....
...In a lawsuit filed last week, Atlantic Coast Life Insurance and Sentinel Security Life Insurance, part of US insurance group A-Cap, asked a New Jersey court to stop AM Best from “issuing the rating it has...
...AstraZeneca is withdrawing its Covid-19 jab, saying there is a “surplus of available updated vaccines” and that its product is no longer being manufactured or supplied....
...The company is contesting a legal case from Jamie Scott, who claims he developed a severe blood clot because he took the vaccine....
...The Bank of England is planning a stress test next year on the effects of a funded reinsurance failure....
...“It’s traditionally been a story that’s popular with UK fund managers. It’s easy to explain, traditionally pays a dividend, and has lots of analyst coverage,” Dixon said....
...Ian Gargan, PHIN chief executive, argued the two sectors “are closely intertwined and support each other, with many staff working in both and patients able to come and go between them depending on their...
...And then there’s Falstaff, dissolute knight, serial chancer and one-time kingpin of his petty-criminal world, superbly portrayed here by Ian McKellen. McKellen, nearly 85, is magnificent....
...ill-health in a given population....
...“It’s a beautiful, big, sexy barrier,” said Hannah Cloke, a professor of hydrology at the University of Reading, adding that the infrastructure had been doing a good job of protecting Londoners right now...
...A couple of weeks ago, Ian McKellen posted a photo of himself in his latest role — a sleazy-looking chap in a black leather jacket clutching a glass of something strong....
...GSK raised its guidance for 2024 on the back of a 10 per cent increase in sales in the first quarter of the year....
...“Getting that to a close is a very important milestone,” Philip’s chief executive Roy Jakobs told the Financial Times....
...The results signal a continued strong start to the year for GSK, whose shares are up by more than 15 per cent since January — well ahead of the FTSE 100, including a rise of almost 2 per cent in morning...
...It recently sold a large site in California to contract manufacturer Lonza for $1.2bn....
...The suit filed in Delaware district court on Thursday is the latest in a string of actions taken against Pfizer and BioNTech over their Comirnaty vaccine....
...Executives at Rolls-Royce expect UK regulators will take four and a half years to assess the safety of its design for a small modular reactor....
...drug breaks down into a carcinogen....
...It has said it expects to open a deeper access channel on May 10, following removal of the Dali....
...than a decade....
...or offer solutions for patients at a later stage.”...
...Smith & Nephew survived a major shareholder revolt over a $2.6mn potential pay rise for its chief executive, in the latest controversy on executive remuneration by UK-listed companies competing with high-paying...
...Butlin’s is suing insurers led by Aviva over a £60mn bill from a flood that shut down its largest holiday resort in a dispute over whether heavy rainfall constituted a “storm”....
...In March, the boss of Admiral said the sector was in a “different situation” and that the FTSE 100 company had even put through a “small price decrease” recently to win business....
...a particular challenge for underwriters....
International Edition